Letter to the editor: Neutralizing antibodies for the treatment of COVID-19
Zeqi Zhou,
Xiangbin Wang,
Yankai Fu,
Xiqing Zhang,
Changxiao Liu
Affiliations
Zeqi Zhou
Dynamiker Biotechnology Sub-Center, Beijing Key Laboratory for Mechanism Study and Precision Diagnosis of Invasive Fungal Diseases, Tianjin 300467, China
Xiangbin Wang
Beijing Antai Zhiyuan Technology Co., Ltd., Beijing 102206, China
Yankai Fu
Dynamiker Biotechnology Sub-Center, Beijing Key Laboratory for Mechanism Study and Precision Diagnosis of Invasive Fungal Diseases, Tianjin 300467, China
Xiqing Zhang
Dynamiker Biotechnology Sub-Center, Beijing Key Laboratory for Mechanism Study and Precision Diagnosis of Invasive Fungal Diseases, Tianjin 300467, China
Changxiao Liu
State Key Laboratory of Drug Delivery Technology and Pharmacokinetics, Tianjin Institute of Pharmaceutical Research, Tianjin 300462, China; Corresponding author.
